TANGO THERAPEUTICS INC's ticker is and the CUSIP is 87583X109. A total of 83 filers reported holding TANGO THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $164,748,656 | +8.1% | 19,201,475 | 0.0% | 81.48% | +10.3% |
| Q1 2024 | $152,459,712 | -20.5% | 19,201,475 | -0.8% | 73.88% | -5.1% |
| Q4 2023 | $191,703,353 | -12.1% | 19,363,975 | 0.0% | 77.88% | -5.2% |
| Q3 2023 | $218,038,359 | +239.2% | 19,363,975 | 0.0% | 82.15% | +41.4% |
| Q2 2023 | $64,288,397 | -15.9% | 19,363,975 | 0.0% | 58.09% | +6.3% |
| Q1 2023 | $76,487,701 | -45.5% | 19,363,975 | 0.0% | 54.67% | -8.4% |
| Q4 2022 | $140,388,819 | +100.3% | 19,363,975 | 0.0% | 59.70% | +45.7% |
| Q3 2022 | $70,098,000 | -20.1% | 19,363,975 | 0.0% | 40.96% | -29.0% |
| Q2 2022 | $87,719,000 | -40.2% | 19,363,975 | 0.0% | 57.68% | +7.3% |
| Q1 2022 | $146,779,000 | -30.7% | 19,363,975 | 0.0% | 53.77% | -11.7% |
| Q4 2021 | $211,842,000 | -15.4% | 19,363,975 | 0.0% | 60.92% | +7.2% |
| Q3 2021 | $250,376,000 | – | 19,363,975 | – | 56.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP IV, LLC | 19,201,475 | $164,748,656 | 81.48% |
| Mass General Brigham, Inc | 354,192 | $3,038,967 | 14.80% |
| Nextech Invest Ltd. | 5,533,980 | $47,481,548 | 7.99% |
| Boxer Capital, LLC | 8,198,642 | $70,344,348 | 3.70% |
| EcoR1 Capital, LLC | 13,330,736 | $114,377,715 | 3.50% |
| Braslyn Ltd. | 26,961 | $231,325 | 2.77% |
| Bain Capital Life Sciences Investors, LLC | 2,892,663 | $24,819,049 | 2.72% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 115,571 | $991,599 | 1.25% |
| Samsara BioCapital, LLC | 630,000 | $5,405,400 | 1.13% |
| Southpoint Capital Advisors LP | 5,276,699 | $45,274,077 | 1.13% |